|
SLC44A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.40570000043361E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.15339999995356E-07 |
| Normal-vs-Stage2 |
9.009800E-02 |
| Normal-vs-Stage3 |
3.641300E-03 |
| Normal-vs-Stage4 |
6.388800E-01 |
| Stage1-vs-Stage2 |
6.797800E-01 |
| Stage1-vs-Stage3 |
9.597900E-02 |
| Stage1-vs-Stage4 |
2.919800E-01 |
| Stage2-vs-Stage3 |
7.348600E-01 |
| Stage2-vs-Stage4 |
3.576600E-01 |
| Stage3-vs-Stage4 |
3.946400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73740000053435E-07 |
| Normal-vs-AfricanAmerican |
6.029600E-02 |
| Normal-vs-Asian |
6.303700E-03 |
| Caucasian-vs-AfricanAmerican |
2.375000E-01 |
| Caucasian-vs-Asian |
9.575400E-01 |
| AfricanAmerican-vs-Asian |
3.552400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.20929932734271E-11 |
| Normal-vs-Female |
4.295600E-01 |
| Male-vs-Female |
1.439580E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.343200E-01 |
| Normal-vs-Extreme_Weight |
1.64490643328463E-12 |
| Normal-vs-Obese |
3.63719999674217E-08 |
| Normal-vs-Extreme_Obese |
3.060800E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.622100E-02 |
| Normal_Weight-vs-Obese |
2.181000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.511200E-01 |
| Extreme_Weight-vs-Obese |
2.946100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.650500E-02 |
| Obese-vs-Extreme_Obese |
6.693400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.373800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.783950E-03 |
| Normal-vs-Age(61-80Yrs) |
6.44719999609578E-09 |
| Normal-vs-Age(81-100Yrs) |
3.82859999999985E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.387200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.622580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.536210E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.128810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.632170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.827200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
6.737900E-03 |
| Normal-VS-KIRP CIMP |
1.320760E-01 |
| Normal-VS-Unclassified PRCC |
2.37670000013956E-07 |
| Type1 PRCC-VS-Type2 PRCC |
6.022300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.397600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.343800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.870000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.443200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.054000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.07310000000561E-05 |
| Normal-vs-N1 |
3.587600E-01 |
| Normal-vs-N2 |
5.245800E-01 |
| N0-vs-N1 |
3.365600E-02 |
| N0-vs-N2 |
4.175000E-01 |
| N1-vs-N2 |
4.943200E-01 |
|
|
